A Double-Blind, Randomized, Parallel, Efficacy Study Evaluating Losartan Potassium Alone or in Combination With Hydrochlorothiazide Versus Placebo in Obese Patients With Elevated Systolic and Diastolic Blood Pressure.
Phase of Trial: Phase III
Latest Information Update: 15 Jul 2014
At a glance
- Drugs Losartan (Primary) ; Hydrochlorothiazide
- Indications Essential hypertension; Hypertension; Obesity
- Focus Therapeutic Use
- Sponsors Merck & Co
- 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 12 May 2009 Actual end date (Mar 2007) added as reported by ClinicalTrials.gov.
- 28 May 2007 Status changed from recruiting to in progress.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History